Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Novel technique to study gene splicing reveals new insights into the process

Novel technique to study gene splicing reveals new insights into the process

UCLA researcher designs ways for immune cells to 'outsmart' solid tumors

UCLA researcher designs ways for immune cells to 'outsmart' solid tumors

Breakthrough discovery could open up new treatments for some blood cancers

Breakthrough discovery could open up new treatments for some blood cancers

Universal 'One-Size-Fits-All' Cancer Treatment

Universal 'One-Size-Fits-All' Cancer Treatment

Smoking cessation goody bag helps people quit smoking

Smoking cessation goody bag helps people quit smoking

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

Researchers develop an emergency stop switch for CAR T-cell therapies

Researchers develop an emergency stop switch for CAR T-cell therapies

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Researchers reveal mutation's role in blood cancers

Researchers reveal mutation's role in blood cancers

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

IU researchers receive $3 million NIH grants to study cell functions in the bone marrow

IU researchers receive $3 million NIH grants to study cell functions in the bone marrow

New research could lead to 'breakthrough' for myelodysplastic syndrome

New research could lead to 'breakthrough' for myelodysplastic syndrome

Death receptor pathway drives resistance to CAR T cell therapy

Death receptor pathway drives resistance to CAR T cell therapy

Study may help develop ibrutinib-based combination therapies for blood cancer

Study may help develop ibrutinib-based combination therapies for blood cancer

Bone marrow chip provides new strategy for understanding Shwachman-Diamond syndrome

Bone marrow chip provides new strategy for understanding Shwachman-Diamond syndrome

Researchers discover how CDK8 oncogene gets activated in healthy humans

Researchers discover how CDK8 oncogene gets activated in healthy humans

Pilot study highlights the effect of chemotherapy on male fertility

Pilot study highlights the effect of chemotherapy on male fertility

International researchers confirm potential inhibitors to combat glioblastoma

International researchers confirm potential inhibitors to combat glioblastoma

Drug profiling and gene editing method open new avenues in the development of CAR T-cell therapy

Drug profiling and gene editing method open new avenues in the development of CAR T-cell therapy

Lab tests reveal that newly discovered T-cell can kill various types of cancer

Lab tests reveal that newly discovered T-cell can kill various types of cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.